Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Randomized controlled trial of clopidogrel to prevent primary arteriovenous fistula failure in hemodialysis patients.

Ghorbani A, Aalamshah M, Shahbazian H, Ehsanpour A, Aref A.

Indian J Nephrol. 2009 Apr;19(2):57-61. doi: 10.4103/0971-4065.53323.

2.

Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.

Kimball TA, Barz K, Dimond KR, Edwards JM, Nehler MR.

J Vasc Surg. 2011 Sep;54(3):760-5; discussion 765-6. doi: 10.1016/j.jvs.2011.03.006. Epub 2011 Jun 23.

3.

Randomized controlled trial of clopidogrel plus aspirin to prevent hemodialysis access graft thrombosis.

Kaufman JS, O'Connor TZ, Zhang JH, Cronin RE, Fiore LD, Ganz MB, Goldfarb DS, Peduzzi PN; Veterans Affairs Cooperative Study Group on Hemodialysis Access Graft Thrombosis.

J Am Soc Nephrol. 2003 Sep;14(9):2313-21.

4.

Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.

Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH.

J Vasc Surg. 2009 Dec;50(6):1359-68.e1. doi: 10.1016/j.jvs.2009.07.108.

5.
6.

Hospital specific aspects predominantly determine primary failure of hemodialysis arteriovenous fistulas.

Huijbregts HJ, Bots ML, Moll FL, Blankestijn PJ; CIMINO members.

J Vasc Surg. 2007 May;45(5):962-7.

7.

The natural history of autologous fistulas as first-time dialysis access in the KDOQI era.

Biuckians A, Scott EC, Meier GH, Panneton JM, Glickman MH.

J Vasc Surg. 2008 Feb;47(2):415-21; discussion 420-1. doi: 10.1016/j.jvs.2007.10.041.

8.

Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial.

Dember LM, Kaufman JS, Beck GJ, Dixon BS, Gassman JJ, Greene T, Himmelfarb J, Hunsicker LG, Kusek JW, Lawson JH, Middleton JP, Radeva M, Schwab SJ, Whiting JF, Feldman HI; DAC Study Group.

Clin Trials. 2005;2(5):413-22.

PMID:
16317810
9.

Clopidogrel two doses comparative 1-year assessment of safety and efficacy (COMPASS) study in Japanese patients with ischemic stroke.

Uchiyama S, Tanahashi N, Minematsu K; COMPASS (SFY6913) Study Group.

Cerebrovasc Dis. 2012;34(3):229-39. doi: 10.1159/000342655. Epub 2012 Sep 25.

PMID:
23018233
10.

The effect of implementation of an optimized care protocol on the outcome of arteriovenous hemodialysis access surgery.

Flu H, Breslau PJ, Krol-van Straaten JM, Hamming JF, Lardenoye JW.

J Vasc Surg. 2008 Sep;48(3):659-68. doi: 10.1016/j.jvs.2008.04.002. Epub 2008 Jun 24.

11.

Aspirin to prevent cardiovascular disease: the association of aspirin dose and clopidogrel with thrombosis and bleeding.

Steinhubl SR, Bhatt DL, Brennan DM, Montalescot G, Hankey GJ, Eikelboom JW, Berger PB, Topol EJ; CHARISMA Investigators.

Ann Intern Med. 2009 Mar 17;150(6):379-86.

PMID:
19293071
12.

Angiotensin receptor blockers and antiplatelet agents are associated with improved primary patency after arteriovenous hemodialysis access placement.

Jackson RS, Sidawy AN, Amdur RL, Khetarpal A, Macsata RA.

J Vasc Surg. 2011 Dec;54(6):1706-12. doi: 10.1016/j.jvs.2011.06.028. Epub 2011 Aug 15.

13.
14.

Axillary artery to contralateral axillary vein graft fistula in chronic hemodialysis patients.

Chuang FR, Hsieh MJ, Lee CH, Chen JB, Cheng YF, Hsu KT, Yang BY, Wu MS.

Ren Fail. 2003 Sep;25(5):871-8.

PMID:
14575295
15.

Outcomes of arteriovenous fistula for hemodialysis in Sudanese patients: single-center experience.

Ahmed GM, Mansour MO, Elfatih M, Khalid KE, Ahmed Mel I.

Saudi J Kidney Dis Transpl. 2012 Jan;23(1):152-7.

16.

Survival of the first arteriovenous fistula in 96 patients on chronic hemodialysis.

Radoui A, Lyoussfi Z, Haddiya I, Skalli Z, El Idrissi R, Rhou H, Ezzaitouni F, Ouzeddoun N, El Mesnaoui A, Bayahia R, Benamar L.

Ann Vasc Surg. 2011 Jul;25(5):630-3. doi: 10.1016/j.avsg.2010.08.011.

PMID:
21724103
17.

Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.

Belch JJ, Dormandy J; CASPAR Writing Committee, Biasi GM, Cairols M, Diehm C, Eikelboom B, Golledge J, Jawien A, Lepäntalo M, Norgren L, Hiatt WR, Becquemin JP, Bergqvist D, Clement D, Baumgartner I, Minar E, Stonebridge P, Vermassen F, Matyas L, Leizorovicz A.

J Vasc Surg. 2010 Oct;52(4):825-33, 833.e1-2. doi: 10.1016/j.jvs.2010.04.027. Epub 2010 Aug 1. Erratum in: J Vasc Surg. 2011 Feb;53(2):564. Biasi, B M [corrected to Biasi, G M].

18.

Clopidogrel decreases arteriovenous fistula thrombosis but does not improve fistula maturation.

Gersch MS.

Nat Clin Pract Nephrol. 2008 Sep;4(9):476-7. doi: 10.1038/ncpneph0908. Epub 2008 Jul 29.

PMID:
18665140
19.
20.

Primary thromboprophylaxis with heparins for arteriovenous fistula failure in pediatric patients.

Sharathkumar A, Hirschl R, Pipe S, Crandell C, Adams B, Lin JJ.

J Vasc Access. 2007 Oct-Dec;8(4):235-44.

PMID:
18161668

Supplemental Content

Support Center